226 related articles for article (PubMed ID: 16965361)
1. Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice.
Varaldo PB; Miyaji EN; Vilar MM; Campos AS; Dias WO; Armôa GR; Tendler M; Leite LC; McIntosh D
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):132-9. PubMed ID: 16965361
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.
Varaldo PB; Leite LC; Dias WO; Miyaji EN; Torres FI; Gebara VC; Armôa GR; Campos AS; Matos DC; Winter N; Gicquel B; Vilar MM; McFadden J; Almeida MS; Tendler M; McIntosh D
Infect Immun; 2004 Jun; 72(6):3336-43. PubMed ID: 15155638
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guérin expressing human immunodeficiency virus type 1 Gag.
Kanekiyo M; Matsuo K; Hamatake M; Hamano T; Ohsu T; Matsumoto S; Yamada T; Yamazaki S; Hasegawa A; Yamamoto N; Honda M
J Virol; 2005 Jul; 79(14):8716-23. PubMed ID: 15994765
[TBL] [Abstract][Full Text] [Related]
4. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.
Fonseca CT; Pacífico LG; Barsante MM; Rassi T; Cassali GD; Oliveira SC
Microbes Infect; 2006 Aug; 8(9-10):2509-16. PubMed ID: 16914349
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y
J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization with Salmonella harboring a Sm14-based DNA vaccine does not protect mice against Schistosoma mansoni infection.
Pacheco LG; Mati VL; Castro TL; Dorella FA; Oliveira SC; Miyoshi A; de Melo AL; Azevedo V
Parasitol Int; 2008 Dec; 57(4):506-8. PubMed ID: 18538627
[TBL] [Abstract][Full Text] [Related]
7. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
[TBL] [Abstract][Full Text] [Related]
8. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
[TBL] [Abstract][Full Text] [Related]
9. [Construction of recombinant BCG bearing Schistosoma japonicum 26Ku antigen gene and study on its immunogenicity on mice].
Dai W; Huangfu Y; Zheng B
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):407-10. PubMed ID: 11798793
[TBL] [Abstract][Full Text] [Related]
10. Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.
Abreu PA; Miyasato PA; Vilar MM; Dias WO; Ho PL; Tendler M; Nascimento AL
Infect Immun; 2004 Oct; 72(10):5931-7. PubMed ID: 15385496
[TBL] [Abstract][Full Text] [Related]
11. Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate.
Ramos CR; Spisni A; Oyama S; Sforça ML; Ramos HR; Vilar MM; Alves AC; Figueredo RC; Tendler M; Zanchin NI; Pertinhez TA; Ho PL
Biochim Biophys Acta; 2009 Apr; 1794(4):655-62. PubMed ID: 19150418
[TBL] [Abstract][Full Text] [Related]
12. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.
Garcia TC; Fonseca CT; Pacifico LG; Durães Fdo V; Marinho FA; Penido ML; Caliari MV; de Melo AL; Pinto HA; Barsante MM; Cunha-Neto E; Oliveira SC
Acta Trop; 2008 Jun; 106(3):162-7. PubMed ID: 18423420
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase.
Kremer L; Riveau G; Baulard A; Capron A; Locht C
J Immunol; 1996 Jun; 156(11):4309-17. PubMed ID: 8666802
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity elicited by rBCG vaccines.
Stover CK; Bansal GP; Langerman S; Hanson MS
Dev Biol Stand; 1994; 82():163-70. PubMed ID: 7958471
[TBL] [Abstract][Full Text] [Related]
15. Overproduction of SM28GST in a baculovirus expression vector and its use to evaluate the in vivo immune responses of mice vaccinated against Schistosoma mansoni with naked DNA encoding the SM28GST gene.
Kayes SG; Shaneyfelt RC; Monteiro C; O'Brien JJ
J Parasitol; 1998 Aug; 84(4):764-70. PubMed ID: 9714208
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a recombinant Mycobacterium bovis bacille Calmette-Guèrin expressing malarial and tuberculosis epitopes.
Rapeah S; Norazmi MN
Vaccine; 2006 Apr; 24(17):3646-53. PubMed ID: 16494975
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity of recombinant Mycobacterium bovis BCG expressing rhomboid gene against Eimeria tenella challenge.
Wang Q; Li J; Zhang X; Liu Q; Liu C; Ma G; Cao L; Gong P; Cai Y; Zhang G
Vet Parasitol; 2009 Mar; 160(3-4):198-203. PubMed ID: 19117681
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
19. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects.
James SL; DeBlois LA
J Immunol; 1986 May; 136(10):3864-71. PubMed ID: 3084645
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of a live Aro attenuated Salmonella vaccine strain expressing 14-kDa Schistosoma mansoni fatty acid-binding protein induced partial protection against experimental schistosomiasis.
Pacheco LG; Zucconi E; Mati VL; Garcia RM; Miyoshi A; Oliveira SC; de Melo AL; Azevedo V
Acta Trop; 2005 Aug; 95(2):132-42. PubMed ID: 15993833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
